Publication | Closed Access

Augmentation of lymphokine-activated killer cell cytotoxicity by monoclonal antibodies against human small cell lung carcinoma

ImmunologyCell DeathImmunologic MechanismMonoclonal AntibodiesImmune Checkpoint InhibitorLung CancerImmunotherapyMedicineRadiation OncologyTumor Microenvironment